JPRN-UMIN000002614已完成2 期
A Phase II study of Glypican-3(GPC3) peptide vaccine as adjuvant treatment for Hepatocellular carcinoma(HCC) after Surgical resection or Radiofrequency ablation(RFA) - A Phase II study of GPC3 peptide vaccine as adjuvant treatment in the prevention of recurrence of HCC
Division of Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East0 个研究点目标入组 40 人开始时间: 2009年10月11日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Evident invasion to the portal vein, hepatic vein, or bile duct 2.Uncontrolled pleural effusion or ascites 3.There are other malignancies 4.Active infection excluding HBV, HCV 5.Clinically significant heart disease (myocardial infarction or unstable angina within the past six months, or uncontrolled cardiac arrhythmias) 6.There are severe complications including cardiac failure, renal failure, liver failure, active gastro-duodenal ulcer, ileus, and uncontrolled Diabetes Mellitus 7.There is severe psychiatric disorder 8.Pregnant or lactating woman, who are willing to be pregnant 9.Past history of severe drug allergy 10.Responsible doctors judged the patient in appropriate for the trial
研究者
相似试验
已完成
1 期
Phase I clinical study of Glypican-3 peptide vaccine in patients with advanced Hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000001395Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East33
已完成
1 期
A Phase I study of Glypican-3(GPC3) Peptide Vaccine for Pediatric Patients with Refractory TumorsRefractory pediatric tumorsJPRN-UMIN000006357Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East15
招募中
1 期
Phase II study of Glypican-3(GPC3) peptide vaccine as treatment for clear cell adenocarcinoma of ovary.JPRN-UMIN000003696Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East140
尚未招募
不适用
Galectin-3 and oral submucous fibrosisCTRI/2020/12/029928Dr Hetvi Sheth
招募中
Unknown
se of Glycomacropeptides (GMP) in 3 – 11 year old children with classical Phenylketonuria in comparison to free amino acid (AAM) supplementation: Effect on metabolic control, micronutrient supply and wellbeing.ORPHA:79254E70.0Classical phenylketonuriaDRKS00031977niversität Leipzig10